About AVT
Browse Articles
Customer Services

Current Issue

Displaying 11 results:

Case report

Primary HIV infection in patients with acute hepatitis B: a report of two cases

Francesca Binda, Elisa Monge, Francesco R Simonetti, Nadia Zanchetta, Massimo Galli, Laura Milazzo, Mario Corbellino, Spinello Antinori

Antiviral Therapy 2018; 23:197-200

Short communication

HIV-1 viral load and resistance in genital secretions in patients taking protease-inhibitor-based second-line therapy in Africa

Anne Hoppe, Marina Giuliano, Abbas Lugemwa, Jennifer A Thompson, Marco Floridia, Ann S Walker, Ismail Senoga, Mary C Abwola, Maria F Pirillo, Cissy M Kityo, Alejandro Arenas-Pinto, Nicholas I Paton, the EARNEST Trial Team

Antiviral Therapy 2018; 23:191-195

Original article

Longitudinal study of falls among HIV-infected and uninfected women: the role of cognition

Anjali Sharma, Donald R Hoover, Qiuhu Shi, Susan Holman, Michael W Plankey, Phyllis C Tien, Kathleen M Weber, Michelle Floris-Moore, Hector H Bolivar, David E Vance, Elizabeth T Golub, Marcia McDonnell Holstad, Michael T Yin

Antiviral Therapy 2018; 23:179-190

Original article

Durability of antiretroviral therapy regimens and determinants for change in HIV-1-infected patients in the TREAT Asia HIV Observational Database (TAHOD-LITE)

Rosario Martinez-Vega, Nicole L De La Mata, Nagalingeswaran Kumarasamy, Penh Sun Ly, Kinh Van Nguyen, Tuti P Merati, Thi Thanh Pham, Man Po Lee, Jun Yong Choi, Jeremy L Ross, Oon Tek Ng

Antiviral Therapy 2018; 23:167-178

Original article

A meta-analysis of laninamivir octanoate for treatment and prophylaxis of influenza

Masayoshi Higashiguchi, Tomoshige Matsumoto, Takashi Fujii

Antiviral Therapy 2018; 23:157-165

Original article

Quantitative measurement of HCV core antigen for management of interferon-free therapy in HCV-infected patients

Mariusz Łucejko, Robert Flisiak

Antiviral Therapy 2018; 23:149-156

Original article

3-Year efficacy and durability of simplification to single tablet regimens: a comparison between co-formulated efavirenz/emtricitabine/tenofovir and rilpivirine/emtricitabine/tenofovir

Roberta Gagliardini, Alessandra Bandera, Mauro Zaccarelli, Gaetana Sterrantino, Alessandra Latini, Alessandro D’Avino, Giuseppe Lapadula, Andrea Antinori, Roberto Cauda, Andrea De Luca, Andrea Gori, Simona Di Giambenedetto, Massimiliano Fabbiani

Antiviral Therapy 2018; 23:139-148

Original article

Sustained virological response by direct antiviral agents in HCV leads to an early and significant improvement of liver fibrosis

Marcello Persico, Valerio Rosato, Andrea Aglitti, Davide Precone, Mariano Corrado, Antonio De Luna, Filomena Morisco, Silvia Camera, Alessandro Federico, Marcello Dallio, Ernesto Claar, Nicola Caporaso, Mario Masarone

Antiviral Therapy 2018; 23:129-138

Original article

Frailty in men living with HIV: a cross-sectional comparison of three frailty instruments

Hui-Ling Yeoh, Allen Cheng, Clovis Palmer, Suzanne M Crowe, Jennifer F Hoy

Antiviral Therapy 2018; 23:117-127

Original article

The association between detected drug resistance mutations and CD4+ T-cell decline in HIV-positive individuals maintained on a failing treatment regimen

Anna Schultze, Roger Paredes, Caroline Sabin, Andrew N Phillips, Deenan Pillay, Nicola Mackie, Antonella Castagna, David Chadwick, Karolin Falconer, Anna Maria Geretti, Frank A Post, Teresa Hill, Ole Kirk, Anton Pozniak, Mark Nelson, Anna Tostevin, David Dunn, Jens Lundgren, Alessandro Cozzi-Lepri

Antiviral Therapy 2018; 23:105-116

Copyright © Nucleus Global 2018. Part of Nucleus Global.
Design and Technology by Nucleus Global
Company registration No. 321 0712 (England & Wales). Registered Office address: Admiral House 76-78 Old Street, London EC1V 9AZ.